Angelman syndrome is a rare disease with a single known cause: one missing gene. The lack of that gene, normally inherited from the mother, occurs in approximately one in 20,000 births and is associated with cognitive and mobility deficits that become evident in children when they are around 6 months old.
Enzyme Buildup Impairs Brain Growth in Mice with Angelman Syndrome
Research on Angelman syndrome reveals that a buildup of a normally harmless enzyme hinders brain growth in mice. This study highlights the genetic basis of the syndrome, which affects cognitive and mobility functions in children. Understanding such genetic disorders can have implications for healthcare policies in Iran, particularly in genetic research and treatment options.
👥 Key Players
📰 What Happened
A study found that an enzyme buildup impairs brain growth in mice with Angelman syndrome, a genetic disorder caused by a missing gene. This research sheds light on the genetic underpinnings of the syndrome and its impact on cognitive and mobility functions.
- Angelman syndrome affects approximately one in 20,000 births.
- The syndrome is characterized by cognitive and mobility deficits that appear in early childhood.
💡 Why It Matters
📚 Background
Angelman syndrome is a genetic disorder caused by a missing gene, leading to significant developmental challenges. Research in this area is crucial for developing effective treatments.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%